Percentage of Novartis pharmaceuticals revenue by therapy area 2019

In 2019, Novartis AG’s Innovative Medicines division generated roughly 40 percent of its revenue through its oncology unit. The oncology branch deals with the study, diagnosis, and treatment of cancer. Approximately 20 percent of the company’s pharmaceuticals revenue was earned through its established medicines unit.


Novartis AG’s pharmaceuticals (Innovative Medicines) was the company’s largest segment by far between 2014 and 2019. In 2019 specifically, the segment earned the company over 38 billion U.S. dollars. The second-largest segment was the Sandoz division, which creates generic pharmaceuticals and biosimilars. Sandoz generated about 10 billion U.S. dollars that year. Just over 70 percent of this segment’s sales numbers were made in established markets, while the remainder was earned in emerging growth markets.

Novartis R&D spending

Novartis AG spent almost nine and a half billion U.S. dollars on research and development in 2019. These are the highest R&D expenses the company has seen between 2004 and 2019. 2019’s R&D expenditures accounted for roughly 20 percent of the company’s total revenue.

Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2019*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2020



Survey time period


Supplementary notes

* The whole Novartis pharmaceuticals segment is called "Innovative Medicines" from 2016 on. It is divided into two business units: Novartis Oncology and Novartis Pharmaceuticals. Percentages were calculated based on given revenue figures and are rounded.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.